plerixafor has been researched along with Cerebral Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TF; Hsieh, ST; Kuo, MF; Lee, JE; Wang, KC; Wu, V; Yang, LY | 1 |
| Li, YZ; Luo, Q; Piao, JM; Wu, W; Yang, ZX; Yu, JL | 1 |
| Englund, E; Issazadeh-Navikas, S; Kuric, E; Liu, Y; Ruscher, K; Walter, HL; Wieloch, T | 1 |
| Chen, SC; He, QW; Hu, B; Huang, M; Huang, Y; Li, YN; Mao, L; Wang, MD; Xia, YP; Zheng, L | 1 |
| Cao, Y; Jolkkonen, J; Li, Y; Qu, H; Xiao, T; Zhao, C; Zhao, M; Zhao, S; Zhao, Y | 1 |
| Huang, J; Li, Y; Tang, G; Tang, Y; Wang, Y; Yang, GY | 1 |
6 other study(ies) available for plerixafor and Cerebral Ischemia
| Article | Year |
|---|---|
Combination of indirect revascularization and endothelial progenitor cell transplantation improved cerebral perfusion and ameliorated tauopathy in a rat model of bilateral ICA ligation.
Topics: Animals; Brain Ischemia; Cerebrovascular Circulation; Chemokine CXCL12; Endothelial Progenitor Cells; Glycogen Synthase Kinase 3 beta; Neovascularization, Physiologic; Rats; Tauopathies | 2022 |
MicroRNA-381 Favors Repair of Nerve Injury Through Regulation of the SDF-1/CXCR4 Signaling Pathway via LRRC4 in Acute Cerebral Ischemia after Cerebral Lymphatic Blockage.
Topics: Animals; Benzylamines; Brain Ischemia; Chemokine CXCL12; Cyclams; Disease Models, Animal; Down-Regulation; Heterocyclic Compounds; Hippocampus; Infarction, Middle Cerebral Artery; Interleukin-1beta; Leucine-Rich Repeat Proteins; Male; MicroRNAs; Mitogen-Activated Protein Kinase 3; Proteins; Rats; Rats, Wistar; Receptors, CXCR4; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A | 2018 |
Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke.
Topics: Animals; Atrophy; Benzylamines; Blotting, Western; Brain; Brain Ischemia; Chemokine CXCL12; Cyclams; DNA; DNA Fragmentation; Down-Regulation; Environment; Flow Cytometry; Fluorescent Antibody Technique; Heterocyclic Compounds; Immunohistochemistry; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Rats; Rats, Inbred SHR; Receptors, CXCR4; Recovery of Function; Signal Transduction; Spleen; Stroke | 2013 |
Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Brain; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Endothelial Progenitor Cells; Heterocyclic Compounds; Infarction, Middle Cerebral Artery; Male; Neovascularization, Physiologic; Rats, Sprague-Dawley; Receptors, CXCR4; Severity of Illness Index; Stroke | 2014 |
CXCR4 antagonist AMD3100 reverses the neurogenesis and behavioral recovery promoted by forced limb-use in stroke rats.
Topics: Animals; Benzylamines; Brain; Brain Ischemia; Central Nervous System Agents; Chemokine CXCL12; Cyclams; Disease Models, Animal; Doublecortin Protein; Endothelin-1; Forelimb; Heterocyclic Compounds; Immobilization; Male; Maze Learning; Motor Activity; Musculoskeletal Manipulations; Neurogenesis; Neurons; Random Allocation; Rats, Wistar; Receptors, CXCR4; Recovery of Function; Stroke; Stroke Rehabilitation | 2015 |
CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice.
Topics: Animals; Benzylamines; Blood-Brain Barrier; Brain Ischemia; Cyclams; Heterocyclic Compounds; Inflammation; Male; Mice; Neuroprotective Agents; Neutrophil Infiltration; Receptors, CXCR4 | 2013 |